Viatris (VTRS) director exercises RSUs and receives new stock award

Rhea-AI Filing Summary

Viatris Inc director MARK RICHARD A reported compensation-related equity activity. On March 6, 2026, previously granted restricted stock units and related dividend equivalent units were exercised, delivering a total of about 24,834 shares of common stock as they vested in full.

The filing also shows a new award of 15,890 restricted stock units, each representing one future Viatris share, scheduled to vest on March 6, 2027. Following these transactions, the director directly holds 116,145 Viatris common shares. All visible derivative awards tied to this filing have now been converted into common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MARK RICHARD A

(Last) (First) (Middle)

1000 MYLAN BOULEVARD

(Street)

CANONSBURG PA 15317

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		23,660	A	$0	114,970	D
Common Stock	03/06/2026		M		1,175(1)	A	$0	116,145	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	03/06/2026		M			23,660	(2)	(2)	Common Stock	23,660	$0	0	D
Dividend Equivalent Units	$0	03/06/2026		M			1,174.4921	(3)	(3)	Common Stock	1,174.4921	$0	0	D
Restricted Stock Units	$0	03/06/2026		A		15,890		(4)	(4)	Common Stock	15,890	$0	15,890	D

Explanation of Responses:

1. Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

2. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.

3. Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.

4. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.

	/s/ Kevin Macikowski, by power of attorney	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Viatris (VTRS) director MARK RICHARD A report?

The director reported exercises of vested restricted stock units and dividend equivalent units plus a new restricted stock unit grant. These are compensation-related acquisitions of Viatris equity rather than open-market stock purchases or sales.

How many Viatris shares did the director acquire through RSU and DEU vesting?

The director acquired about 24,834 Viatris common shares through the vesting and exercise of restricted stock units and associated dividend equivalent units on March 6, 2026, as part of previously granted equity awards.

What new equity award did the Viatris (VTRS) director receive in this Form 4?

The director received a new grant of 15,890 restricted stock units, each representing one future share of Viatris common stock. According to the filing, these units are scheduled to vest on March 6, 2027, subject to the award’s terms.

How many Viatris shares does the director hold after these transactions?

After the reported exercises and grants, the director directly holds 116,145 shares of Viatris common stock. This total reflects the additional shares received from vested equity awards reported in the Form 4 filing on March 6, 2026.

Were any Viatris (VTRS) shares sold in this Form 4 filing?

No sales were reported. All transactions involve the exercise or conversion of restricted stock units and dividend equivalent units, plus a new grant of restricted stock units, which are routine components of the director’s equity-based compensation.

When do the newly granted Viatris restricted stock units vest?

The newly granted restricted stock units are scheduled to vest on March 6, 2027. Each unit represents the right to receive one share of Viatris common stock if the vesting conditions described in the award agreement are satisfied.